0001209191-19-048011.txt : 20190903
0001209191-19-048011.hdr.sgml : 20190903
20190903172349
ACCESSION NUMBER: 0001209191-19-048011
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190829
FILED AS OF DATE: 20190903
DATE AS OF CHANGE: 20190903
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: JANNEY DANIEL
CENTRAL INDEX KEY: 0001198325
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38210
FILM NUMBER: 191072771
MAIL ADDRESS:
STREET 1: ONE EMBARCADERO CENTER SUITE 3700
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Krystal Biotech, Inc.
CENTRAL INDEX KEY: 0001711279
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 810930882
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2100 WHARTON STREET
STREET 2: SUITE 701
CITY: PITTSBURGH
STATE: PA
ZIP: 15203
BUSINESS PHONE: (412) 586-5830
MAIL ADDRESS:
STREET 1: 2100 WHARTON STREET
STREET 2: SUITE 701
CITY: PITTSBURGH
STATE: PA
ZIP: 15203
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-08-29
0
0001711279
Krystal Biotech, Inc.
KRYS
0001198325
JANNEY DANIEL
2100 WHARTON STREET
SUITE 701
PITTSBURGH
PA
15203
1
0
0
0
Common Stock
2019-08-29
4
S
0
55794
46.61
D
399252
I
See footnotes
Common Stock
2019-08-29
4
S
0
700
47.50
D
398552
I
See footnotes
Common Stock
2019-08-30
4
S
0
32190
46.18
D
366362
I
See footnotes
This transaction was executed in multiple trades ranging from $46.43 to $47.42. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Directly beneficially owned by Alta Bioequities, L.P.
Alta Bioequities Management, LLC is the general partner of Alta Bioequities, L.P. and may be deemed to have sole voting and investment power over the shares beneficially owned by Alta Bioequities, L.P. The reporting person is the Managing Director of Alta Bioequities Management, LLC. The reporting person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
This transaction was executed in multiple trades ranging from $47.43 to $47.69. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
This transaction was executed in multiple trades ranging from $46.03 to $46.60. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
/s/ Daniel S. Janney
2019-09-03